Novartis AG (NVSEF)

101.99 +5.31 (+5.49%) USD  |  OTCM  |  May 10, 15:56
More

Novartis Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for NVSEF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical Underperform Recommendations Data

View and export this data back to 2023. Upgrade now.
Date Value
November 21, 2023 --
Date Value
September 14, 2023 --

Underperform Recommendations Range, Past 5 Years

--
Minimum
Sep 14 2023
--
Maximum
Sep 14 2023
--
Average
--
Median
Sep 14 2023

Underperform Recommendations Benchmarks

Sandoz Group AG --
Roche Holding AG Upgrade
Bristol-Myers Squibb Co Upgrade
ADC Therapeutics SA Upgrade